¼¼°èÀÇ µ¿°áº¸Á¸ Àåºñ ½ÃÀå
Cryopreservation Equipment
»óǰÄÚµå : 1567993
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 279 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,266,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,798,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

µ¿°áº¸Á¸ Àåºñ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 171¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â 81¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â µ¿°áº¸Á¸ Àåºñ ¼¼°è ½ÃÀåÀº 2023-2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 11.4 %·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 171¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ³Ãµ¿°í´Â CAGR 12.1%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 74¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. »ùÇà Á¶Á¦ ½Ã½ºÅÛ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 10.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 22¾ï ´Þ·¯, Áß±¹Àº CAGR 15.5%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ µ¿°áº¸Á¸ Àåºñ ½ÃÀåÀº 2023³â 22¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 37¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³â ºÐ¼® ±â°£ µ¿¾È 15.5%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 8.5%¿Í 9.9%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¾à 9.0%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è µ¿°áº¸Á¸ Àåºñ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

¿Ö µ¿°áº¸Á¸ Àåºñ°¡ »ý¸í°øÇÐ ¹× ÇコÄɾ ÇʼöÀûÀΰ¡?

µ¿°áº¸Á¸ Àåºñ´Â »ý¹°ÇÐÀû »ùÇÃ, ¼¼Æ÷, Á¶Á÷, Àå±â¸¦ ÃÊÀú¿ÂÀ¸·Î º¸Á¸ÇÏ¿© ÀÇÇÐ ¿¬±¸, À̽Ä, Ä¡·á¸¦ À§ÇÑ Àå±âÀûÀÎ »ýÁ¸¼ºÀ» º¸ÀåÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. µ¿°áº¸Á¸Àº ¹ÙÀÌ¿À¹ðÅ·, Áٱ⼼Æ÷ ¿¬±¸, ºÒÀÓÄ¡·á, Àç»ýÀÇ·á µîÀÇ ºÐ¾ß¿¡¼­ ³Î¸® Ȱ¿ëµÇ°í ÀÖÀ¸¸ç, »ý¹°ÇÐÀû ¹°ÁúÀÇ ¹«°á¼ºÀ» ¼Õ»ó½ÃŰÁö ¾Ê°í º¸Á¸ÇÒ ¼ö ÀÖ´Â ´É·ÂÀÌ ÇʼöÀûÀÔ´Ï´Ù. ¼¼Æ÷ ±â¹Ý Ä¡·á¹ýÀÇ Áõ°¡, °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ ¹ßÀü, Àå±â À̽Ŀ¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ´Â ÀúÀå ¹× ÃßÃâ ±â´ÉÀ» Á¦°øÇÏ´Â µ¿°áº¸Á¸ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô µ¿°áº¸Á¸ Àåºñ¸¦ °­È­Çϴ°¡?

µ¿°áº¸Á¸ ÀåºñÀÇ Çõ½ÅÀº º¸Á¸ È¿À², ½Å·Ú¼º ¹× ½Ã·áÀÇ ¾ÈÀü¼ºÀ» Å©°Ô Çâ»ó½ÃÄ×½À´Ï´Ù. ÷´Ü ±ØÀú¿Â ³Ãµ¿°í¿Í ¾×ü Áú¼Ò ÅÊÅ©´Â Á¤¹ÐÇÑ ¿Âµµ Á¦¾î ¹× ¸ð´ÏÅ͸µÀ» ÅëÇØ ½Ã·á°¡ ¿­È­¸¦ ¹æÁöÇÏ´Â µ¥ ÇÊ¿äÇÑ ÃÊÀú¿Â ¹üÀ§¿¡ ¸Ó¹«¸¦ ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù. ÀÚµ¿È­¿Í IoTÀÇ ÅëÇÕÀº ½Ç½Ã°£ ÃßÀû, ¿ø°Ý ¸ð´ÏÅ͸µ ¹× ½Ã·áÀÇ ÀÚµ¿ ȸ¼ö¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â µî ±ØÀú¿Â º¸Á¸¿¡ º¯È­¸¦ °¡Á®¿Ô½À´Ï´Ù. ¶ÇÇÑ, µ¿°á º¸È£Á¦(µ¿°á Áß ¼¼Æ÷ ¼Õ»óÀ» ¹æÁöÇÏ´Â È­ÇÕ¹°)ÀÇ Çõ½ÅÀº Áٱ⼼Æ÷, ¹è¾Æ µî º¸´Ù ¼¶¼¼ÇÑ »ý¹°ÇÐÀû ¹°ÁúÀÇ º¸Á¸ ¼º°ø·üÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ¿¬±¸ ¹× ÀÓ»ó ÀÀ¿ë ºÐ¾ß¿¡¼­ µ¿°áº¸Á¸ Àç·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ µÞ¹ÞħÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

µ¿°áº¸Á¸ ½ÃÀåÀ» Çü¼ºÇÏ´Â ±ÔÁ¦ ¹× ¾ÈÀü ±âÁØÀº ¹«¾ùÀΰ¡?

µ¿°áº¸Á¸ ½ÃÀåÀÇ ±ÔÁ¦ ±âÁØÀº ¾ö°ÝÇϸç, ƯÈ÷ ÀÇ·á ¹× Á¦¾à µî »ý¹°ÇÐÀû ½Ã·áÀÇ ¹«°á¼ºÀÌ Áß¿äÇÑ ºÐ¾ß¿¡¼­´Â FDA, À¯·´ÀǾàǰû(EMA), ±¹Á¦»ý¹°È¯°æº¸Á¸Çùȸ(ISBER) µî ¿©·¯ ±â°ü¿¡¼­ µ¿°áº¸Á¸ ¹°ÁúÀÇ ÀûÀýÇÑ Ãë±Þ, º¸°ü ¹× ¿î¼Û¿¡ ´ëÇÑ °¡À̵å¶óÀÎÀ» Á¦Á¤Çϰí ÀÖ½À´Ï´Ù. °¡À̵å¶óÀÎÀ» Á¦Á¤Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âÁØÀº »ý¹°ÇÐÀû ½Ã·á°¡ ÇâÈÄ ÀÓ»ó ¹× ¿¬±¸ ȯ°æ¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖµµ·Ï »ýÁ¸ °¡´É¼ºÀ» À¯ÁöÇÒ ¼ö ÀÖ´Â Á¶°Ç¿¡¼­ º¸°üµÇµµ·Ï º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ, ³Ãµ¿º¸°ü Àåºñ Á¦Á¶¾÷ü´Â ¹Î°¨ÇÑ ÀÀ¿ë ºÐ¾ß¿¡¼­ Á¦Ç°ÀÇ ¾ÈÀü¼º°ú ½Å·Ú¼ºÀ» º¸ÀåÇϱâ À§ÇØ ¿ì¼öÀǾàǰÁ¦Á¶°ü¸®±âÁØ(GMP)À» ÁؼöÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù.

µ¿°áº¸Á¸ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

µ¿°áº¸Á¸ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀº ¹ÙÀÌ¿À¹ðÅ©ÀÇ Ã¤Åà Áõ°¡, Àç»ý ÀÇÇÐÀÇ ¹ßÀü, ¼¼Æ÷ ±â¹Ý Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Áٱ⼼Æ÷, ¸é¿ªÄ¡·á, ¸ÂÃãÀÇ·á¿¡ ´ëÇÑ ¿¬±¸°¡ È®´ëµÊ¿¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ´Â µ¿°áº¸Á¸ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ãâ»ê Áö¿¬°ú ¾Ï Ä¡·á·Î ÀÎÇÑ °¡ÀÓ·Â º¸Á¸ÀÇ Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àå±â ÀÌ½Ä ¹× Á¶Á÷ À̽Ŀ¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Àå±âÀûÀ¸·Î »ý¹°ÇÐÀû »ýÁ¸·ÂÀ» À¯ÁöÇÒ ¼ö Àִ ÷´Ü µ¿°áº¸Á¸ ½Ã½ºÅÛÀÇ °³¹ßÀÌ ÃËÁøµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ÇコÄÉ¾î ¹× »ý¸í°øÇÐÀÇ ±¤¹üÀ§ÇÑ ºÐ¾ß¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(36°³»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cryopreservation Equipment Market to Reach US$17.1 Billion by 2030

The global market for Cryopreservation Equipment estimated at US$8.1 Billion in the year 2023, is expected to reach US$17.1 Billion by 2030, growing at a CAGR of 11.4% over the analysis period 2023-2030. Freezers, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$7.4 Billion by the end of the analysis period. Growth in the Sample Preparation Systems segment is estimated at 10.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 15.5% CAGR

The Cryopreservation Equipment market in the U.S. is estimated at US$2.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2030 trailing a CAGR of 15.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.5% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.0% CAGR.

Global Cryopreservation Equipment Market - Key Trends & Drivers Summarized

Why Is Cryopreservation Equipment Vital for Biotechnology and Healthcare?

Cryopreservation equipment is crucial in preserving biological samples, cells, tissues, and organs at ultra-low temperatures, ensuring their long-term viability for medical research, transplantation, and therapy. Cryopreservation is widely used in the biobanking, stem cell research, fertility treatments, and regenerative medicine fields, where the ability to store biological materials without compromising their integrity is essential. The rise in cell-based therapies, advancements in personalized medicine, and the growing need for organ transplants are driving demand for cryopreservation solutions that offer reliable storage and retrieval capabilities.

How Are Technological Advances Enhancing Cryopreservation Equipment?

Technological innovations in cryopreservation equipment are significantly improving storage efficiency, reliability, and sample safety. Advanced cryogenic freezers and liquid nitrogen tanks now offer precise temperature control and monitoring, ensuring that samples remain within the required ultra-low temperature range to prevent degradation. Automation and IoT integration are also transforming cryopreservation, allowing real-time tracking, remote monitoring, and automated sample retrieval. Additionally, innovations in cryoprotectants—compounds that prevent cell damage during freezing—are improving the success rate of preserving more sensitive biological materials, such as stem cells and embryos. These technological advancements are essential in supporting the growing demand for cryopreserved materials in research and clinical applications.

What Regulatory and Safety Standards Shape the Cryopreservation Market?

Regulatory standards in the cryopreservation market are stringent, particularly in sectors such as healthcare and pharmaceuticals, where the integrity of biological samples is critical. Organizations like the FDA, European Medicines Agency (EMA), and International Society for Biological and Environmental Repositories (ISBER) have established guidelines for the proper handling, storage, and transportation of cryopreserved materials. These standards ensure that biological samples are preserved in conditions that maintain their viability for future use in clinical and research settings. Adherence to Good Manufacturing Practices (GMP) is also essential for cryopreservation equipment manufacturers to ensure the safety and reliability of their products in sensitive applications.

What Factors Are Driving the Growth of the Cryopreservation Equipment Market?

The growth in the cryopreservation equipment market is driven by several factors, including the increasing adoption of biobanking, advancements in regenerative medicine, and the growing demand for cell-based therapies. As research into stem cells, immunotherapy, and personalized medicine expands, the need for reliable cryopreservation solutions is becoming more critical. The rise in fertility preservation, driven by delayed parenthood and cancer treatments, is also contributing to market growth. Additionally, the increased demand for organ and tissue transplants is pushing the development of advanced cryopreservation systems that can maintain biological viability over extended periods, supporting the broader healthcare and biotechnology sectors.

Select Competitors (Total 36 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â